CD4 regulates susceptibility to Fas ligand- and tumor necrosis factor- mediated apoptosis

Journal of Experimental Medicine

Volumn 187, Issue 5, 1998, Pages 711-720

  Algeciras, Alicia ^a   Dockrell, David H ^b   Lynch, David H ^c   Paya, Carlos V ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; TUMOR NECROSIS FACTOR;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CROSS LINKING; HELPER CELL; LIGAND BINDING; LYMPHOCYTE FUNCTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

ANTIGENS, CD4; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FAS LIGAND PROTEIN; HUMANS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; PROTEIN KINASE C; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032473552     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.5.711     Document Type: Article

References (55)

1. Boehme, S.A., L. Zheng, and M.J. Leonardo. 1995. Analysis of CD4 coreceptor and activation-induced costimulatory molecules in antigen-mediated mature T lymphocyte death. J. Immunol. 155:1703-1712.
2. Van Parijs, L., A. Ibraghimov, and A.K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity. 4:321-328.
3. Krammer, P.H., I. Behrmann, P. Daniel, J. Dhein, and K.-M. Debatin. 1994. Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 6:279-289.
4. Sytwu, H.-K., R.S. Liblau, and H.O. McDevitt. 1996 The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity. 5:17-30.
5. Katsikis, P. D., E.S. Wunderlich, C.A. Smith, L.A. Herzenberg, and L.A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181: 2029-2036.
6. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor J. Exp. Med. 185:55-64.
7. Banda, N.K., J. Bernier, D.K. Kurahara, R. Kurrle, N. Haigwood, R.-P. Sekaly, and T.H. Finkel. 1992. Cross-linking CD4 by human immunodeficiency virus gp120 primers T cells for activation-induced apoptosis. J. Exp. Med. 176: 1099-1106.
8. Oyaizu, N., T.W. McCloskey, M. Coronesi, N. Chirmule, V.S. Kalyanaraman, and S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood. 82:3393-3400.
9. Wang, Z.-Q., A. Dudhane, T. Orlikowsky, K. Clarke, X. Li, Z. Darzynkiewicz, and M.K. Hoffmann. 1994. CD4 engagement induces Fas antigen-dependent apoptosis of T cells in vivo. Eur. J. Immunol. 24:1549-1552.
10. + T cells. Proc. Natl. Acad. Sci. USA. 93:11014-11018.
11. Oyaizu, N., T.W. McCloskey, S. Than, R. Hu, V.S. Kalyanaraman, and S. Pahwa. 1994 Cross-linking of CD4 molecules upregulates Fas antigen expression in lymphocytes by inducing interferon-γ and tumor necrosis factor-α secretion. Blood. 84:2622-2631.
12. Alderson, M.R., T.W. Tough, S. Braddy, T. Davis-Smith, E. Roux, K. Schooley, R.E. Miller, and D.H. Lynch. 1994. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6:1799-1806.
13. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
14. Badley, A.D., J.A. McElhinny, P.J. Leibson, D.H. Lynch, M.R. Alderson, and C.V. Paya. 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:199-206.
15. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777-1783.
16. Hatch, W.C., K.E. Tanaka, T. Calcelli, W.K. Rashbaum, Y. Kress, and W.D. Lyman. 1992. Persistent productive HIV-1 infection of a CD4-human fetal thymocyte line. J. Immunol. 148:3055-3061.
17. Page, K.A., S.M. Stearns, and D.R. Littman. 1992. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J. Virol. 66:524-533.
18. Ormerod, M.G., X.-M. Sun, D. Brown, R.T. Snowden, and G.M. Cohen. 1993. Quantification of apoptosis and necrosis by flow cytometry. Acta Oncol. 32:417-424.
19. Peter, M.E., F.C. Kischkel, S. Hellbardt, A.M. Chinnaiyan, P.H. Krammer, and V.M. Dixit. 1996. CD95 (APO-1/Fas)-associating signaling proteins. Cell Death Diff. 3:161-170.
20. Baker, S.J., and E.P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12:1-9.
21. Baldari, C.T., M.M. Di Somma, E. Milia, M. Bergman, and J.L. Telford. 1995. Interactions between the tyrosine kinases p561ck, p59fyn and p50csk in CD4 signaling in T cells. Eur. J. Immunol. 25:919-925.
22. Di Somma, M.M., S. Nuti, J.L. Telford, and C.T. Baldari. 1995. p561ck plays a key role in transducing apoptotic signals in T cells. FEBS Lett. 363:101-104.
23. Kornfeld, H., W.W. Cruikshank, S.W. Pyle, J.S. Berman, and D.M. Center. 1988. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature. 335:445-448.
24. Baldari, C.T., E. Milia, M.M. Di Somma, F. Baldoni, S. Valitutti, and J.L. Telford. 1995. Distinct signaling properties identify functionally different CD4 epitopes. Eur. J. Immunol. 25:1843-1850.
25. Prada, N.A., W.W. Cruikshank, H.L. Danis, T.C. Ryan, and D.M. Center. 1996. IL-16 and other ligand-induced migration is dependent upon protein kinase C. Cell. Immunol. 168: 100-106.
26. Ushijima, H., S. Ando, T. Kunisada, H.C. Schröder, H.-P. Klöcking, A. Kijjoa, and W.E.G. Muller. 1993. HIV-1 gp120 and NMDA induce protein kinase C translocation differentially in rat primary neuronal cultures. J. Acquired Immune Defic. Syndr. 6:339-343.
27. Gupta, S., S. Aggarwal, C. Kim, and S. Gollapudi. 1994. Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes - a preliminary report. Int. J. Immunopharmacol. 16:197-204.
28. +2 levels. Microbiologica (Pavia). 17:85-92.
29. Berry N., and Y. Nishizuka. 1990. Protein kinase C and T cell activation. Euro. J. Biochem. 189:205-214.
30. Genot, E.M., P.J. Parker, and D.A. Cantrell. 1995. Analysis of the role of protein kinase C-α, -∈ and -ζ in T cell activation. J. Biol. Chem. 270:9833-9839.
31. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
32. Ju, S.-T., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL Interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
33. Yang, Y., M. Merćep, C.F. Ware, and J.D. Ashwell. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181:1673-1682.
34. Kiener, P.A., P.M. Davis, G.C. Starling, C. Mehlin, S.J. Klebanoff, J.A. Ledbetter, and W.C. Liles. 1997. Differential induction of apoptosis by Fas-Fas ligand interactions in human monocytes and macrophages. J. Exp. Med. 185:1511-1516.
35. Westendorp, M.O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P.H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature: 375:497-500.
36. + T cell apoptosis. J. Immunol. 158:2456-2463.
37. Wang, Z., A. Dudhane, T. Orlikowsky, and M.K. Hoffmann. 1995. T cell antigen receptor engagement abrogates CD4-mediated T cell deletion in vivo. Int. Immunol. 7:207-211.
38. L. Immunity. 3:87-98.
39. Lenert, G., and P. Lenert. 1996. Human CD4-reactive antibodies from SLE patients induce reversible inhibition of polyclonal T lymphocyte proliferation. Hum. Immunol. 49: 113-121.
40. + lymphocytes in human immunodefiency virus type 1 seroconverters. J. Infect. Dis. 171: 312-319.
41. + lymphocytes in human immunodeficiency virus type 1 seroconverters. Immunol. Lett. 41:163-167.
42. Burastero, S.E., D. Gaffi, L. Lopalco, G. Tambussi, B. Borgonovo, C. De Santis, C. Abecasis, P. Robbioni, A. Gasparri, A. Lazzarin et al. 1996. Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals. AIDS Res. Hum. Retroviruses. 12:273-280.
43. Oh, S.K., W.W. Cruikshank, J. Raina, G.C. Blanchard, W.H. Adler, J. Walker, and H. Kornfeld. 1992. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. Acquired Immune Defic. Syndr. 5:351-356.
44. Ellaurie, M., T.A. Calvelli, and A. Rubinstein. 1990. Human immunodeficiency virus (HIV) circulating immune complexes in infected children. AIDS Res. Hum. Retroviruses. 6: 1437-1441.
45. Feijoó, E., D. Subirá, M. Gerández-Guerrero, R. Garcia, and F. Oritz. 1995. Anti-CD4 activity in circulating immune complexes in HIV-infected patients. Int. Arch. Allergy Immunol. 106:366-371.
46. Wei, X., S.K. Ghosh, M.E. Taylor, V.A. Johnson, E.A. Emini, P. Deutsch. J.D. Lifson, S. Bonhoeffer, M.A. Nowak, B.H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:117-122.
47. Ho, D.D., A.U. Neumann, A.S. Perelson, W. Chen, J.M. Leonard and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:123-126.
48. Bilello, J.A., K. Stellrecht, G.L. Drusano, and D.S. Stein. 1996. Soluble tumor necrosis factor-α receptor type II (STNF α RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J. Infect. Dis. 173:464-467.
49. Macchia, D., F. Almerigogna, V. Parronchi, A. Ravina, E. Maggie, and S. Romagnani. 1993. Membrane tumour necrosis factor-α involved in the polyclonal B cell activation induced by HIV-infected human T cells. Nature. 363:464-466.
50. Sawai, H., T. Okazaki, Y. Takeda, M. Tashima, H. Swada, M. Okuma, S. Kishi, H. Umehara, and N. Domae. 1997. Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol: implifications in apoptosis. J. Biol. Chem. 272:2452-2458.
51. Chinnaiyan, A.M., C.G. Tepper, M.F. Seldin, K. O'Rourke, F.C. Kischkel, S. Hellbardt, P.H. Krammer, and V.M. Dixit. 1996. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis. J. Biol. Chem. 9:4961-4965.
52. Baker, S.J., and E.P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene. 12:1-9.
53. Boldin, M.P., T.M. Goncharov, Y.V. Goltsev, and D. Wallach. 1996. Involvement of MACH, a novel MORT1/ FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell. 85:803-815.
54. Muzio, M., A.M. Chinnaiyan, F.C. Kischel, K. O'Rourke, A. Shevchenco, J. Ni, C. Scaffidi, J.D. Bretz, M. Zhang, R. Gentz, et al. 1996. FLICE, a novel FADD-homolgous ICE/ CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85:817-827.
55. Fraser, A., and G. Evan. 1996. A license to kill. Cell. 85: 781-784.